President Trump recently issued an executive order, aiming to lower prescription costs down for Americans by aligning prices with those paid in other wealthy nations. The policy introduces a most ...

Trump’s most-favored-nation executive order would collapse the American pharmaceutical industry’s innovation edge.

Will the U.S. government adopt price controls on prescription drugs? If so, what would they look like? Seeking Alpha analysts ...

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will ...

In a webinar, panelists discuss Trump's 2025 drug pricing policies, focusing on the Most Favored Nation order, pharmacy ...

US president’s ‘most favoured nation’ policy could also lead to European patients losing access to new treatments ...

President Trump signed an executive order that day requiring health secretary Robert F. Kennedy Jr. to set price goals within 30 days, setting the stage for negotiations between the drug companies ...

Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.

President Trump posted on his platform Truth Social in anticipation of the order’s signing: “Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.” ...

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...